© 2022 BioMarin. All rights reserved.
| Recent Price | $85.06 |
|---|---|
| 52 Week High | $97.76 |
| 52 Week Low | $70.73 |
| Average Volume (30 days) | 912.85K |
| Beta | 0.32 |
| Market Cap | $15.78B |
|---|---|
| Shares Outstanding | 185.47M |
| Float | 184.65M |
| Yield % | -- |
|---|---|
| Annual Dividend | -- |
| Payout Ratio | -285.7% |
| Quick Ratio (MRQ) | 3.4 |
|---|---|
| Current Ratio (MRQ) | 5.4 |
| LT Debt/Capital (MRQ) | 19% |
| Total Debt/Equity (MRQ) | 24% |
| Price/Earnings (TTM) | 330.20 |
|---|---|
| Price/Sales (TTM) | 8.25 |
| Price/Book (MRQ) | 3.53 |
| Price/Cash Flow (TTM) | 134.00 |
| Earnings (TTM) | $0.26 |
|---|---|
| Sales (TTM) | $10.31 |
| Book Value (MRQ) | $24.29 |
| Cash Flow (TTM) | $0.64 |
| Cash (MRQ) | $5.99 |
| Return on Equity (TTM) | 1.3% |
|---|---|
| Return on Assets (TTM) | 1.0% |
| Return on Investment (TTM) | 1.1% |
| Gross Margin (TTM) | 75.8% |
|---|---|
| EBIT Margin (TTM) | 3.7% |
| Profit Margin (TTM) | 3.0% |